COVID-19 antiviral therapy for non-hospitalised immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.
Chung M A LinJosh BennettLavanya RajagopalaEwan HunterAlice R LorenziBridget GriffithsKenneth F BakerPublished in: Rheumatology (Oxford, England) (2022)